Related Experiment Video
Updated: Apr 21, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest
Wen Pan1, Yingying Cheng1, Heyu Zhang2
1Department of Immunology, Center for Human Disease Genomics, Key Laboratory of Medical Immunology, Ministry of Health, School of Basic Medical Sciences, Peking University, Beijing, China.
Abstract:
Cytokines are soluble proteins that exert their functions by binding specific receptors. Many cytokines play essential roles in carcinogenesis and have been developed for the treatment of cancer. In this study, we identified a novel potential cytokine using immunogenomics designated colon-derived SUSD2 binding factor (CSBF), also known as chromosome 10 open reading frame 99 (C10orf99). CSBF/C10orf99 is a classical secreted protein with predicted molecular mass of 6.5 kDa, and a functional ligand of Sushi Domain Containing 2 (SUSD2). CSBF/C10orf99 has the highest expression level in colon tissue. Both CSBF/C10orf99 and SUSD2 are down-regulated in colon cancer tissues and cell lines with different regulation mechanisms. CSBF/C10orf99 interacts with SUSD2 to inhibit colon cancer cell growth and induce G1 cell cycle arrest by down-regulating cyclin D and cyclin-dependent kinase 6 (CDK6). CSBF/C10orf99 displays a bell-shaped activity curve with the optimal effect at ~10 ng/ml. Its growth inhibitory effects can be blocked by sSUSD2-Fc soluble protein. Our results suggest that CSBF/C10orf99 is a novel potential cytokine with tumor suppressor functions.
Insights
Researchers discovered colon-derived SUSD2 binding factor (CSBF), also known as C10orf99, a novel cytokine. This protein inhibits colon cancer cell growth and acts as a tumor suppressor, offering new therapeutic avenues.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Cytokines are crucial signaling proteins in biological processes, including cancer.
- Many cytokines are implicated in carcinogenesis and are targets for cancer therapy.
Purpose of the Study:
- To identify and characterize a novel cytokine involved in colon cancer.
- To elucidate the functional role of this new cytokine in colon cancer progression.
Main Methods:
- Immunogenomic screening to identify novel proteins.
- Expression analysis in colon cancer tissues and cell lines.
- In vitro assays to determine protein function and interaction with SUSD2.
Main Results:
- Identified colon-derived SUSD2 binding factor (CSBF)/C10orf99 as a novel secreted cytokine.
- CSBF/C10orf99 and SUSD2 are downregulated in colon cancer.
- CSBF/C10orf99 inhibits colon cancer cell proliferation and induces G1 cell cycle arrest via SUSD2 interaction.
Conclusions:
- CSBF/C10orf99 is a potential tumor suppressor cytokine in colon cancer.
- CSBF/C10orf99-SUSD2 interaction represents a novel mechanism in colon cancer regulation.
- CSBF/C10orf99 warrants further investigation as a therapeutic target.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Abnormal Proliferation
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and...

